Skip to main content
. Author manuscript; available in PMC: 2019 Sep 26.
Published in final edited form as: Mol Pharm. 2019 Jun 19;16(7):3065–3071. doi: 10.1021/acs.molpharmaceut.9b00293

Figure 1.

Figure 1.

The design of the β-elimination prodrug strategy to target FabB/FabF in the fatty acid biosynthesis pathway in Staphylococcus aureus, using the PTM-inspired thioether analogue PTM-2t.